Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, J., Grunze, H., Holmes, E., Howes, O., Hudson, S., Hunt, N., Jones, Ian Richard ORCID: https://orcid.org/0000-0001-5821-5889, Macmillan, I., McAllister-Williams, H., Miklowitz, D., Morriss, R., Munafo, M., Paton, C., Saharkian, B., Saunders, K., Sinclair, J., Taylor, D., Vieta, E. and Young, A. 2016. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 30 (6) , pp. 495-553. 10.1177/0269881116636545

Preview

PDF - Accepted Post-Print Version Download (1MB) | Preview

Abstract

The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. The use of medication is integrated with a coherent approach to psychoeducation and behaviour change.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Subjects:	R Medicine > R Medicine (General)
Uncontrolled Keywords:	Bipolar disorder, treatment, evidence-based guidelines, antipsychotics, antidepressants, mood stabilizers, lithium, psychoeducation, cognitive behaviour therapy
Publisher:	SAGE Publications (UK and US)
ISSN:	0269-8811
Date of First Compliant Deposit:	10 November 2016
Date of Acceptance:	14 March 2016
Last Modified:	16 Nov 2024 22:00
URI:	https://orca.cardiff.ac.uk/id/eprint/95996

Citation Data

Cited 379 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item